Alza
Executive Summary
Palo Alto, California-based drug delivery systems company increases size of planned offering of "liquid yield option" notes, or LYONs, due Dec. 21, 2010 from $600 mil. to $750 mil. Each LYON is being offered at a price of $229.34 per $1,000 principal amount at maturity. Merrill Lynch is underwriting the offering. Alza will net approximately $166.4 mil., which will be used for general corporate purposes.